Jan G. den Hollander

2.6k total citations
32 papers, 1.2k citations indexed

About

Jan G. den Hollander is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Jan G. den Hollander has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Jan G. den Hollander's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Jan G. den Hollander is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Antibiotic Resistance in Bacteria (10 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Jan G. den Hollander collaborates with scholars based in Netherlands, United States and Denmark. Jan G. den Hollander's co-authors include Johan W. Mouton, Henri A. Verbrugh, Mart J Mantel, Arie Berghout, Hok Bing Thio, Hannelore M Götz, Onno de Zwart, Gerard van Doornum, Hubert G.M. Niesters and Kurt Fuursted and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Jan G. den Hollander

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan G. den Hollander Netherlands 16 477 473 371 289 167 32 1.2k
Sandra L. Preston United States 25 1.1k 2.4× 941 2.0× 676 1.8× 519 1.8× 139 0.8× 45 2.4k
Laurel C. Preheim United States 22 244 0.5× 687 1.5× 218 0.6× 283 1.0× 140 0.8× 51 1.3k
Katie E. Barber United States 21 405 0.8× 471 1.0× 371 1.0× 827 2.9× 69 0.4× 89 1.5k
I. M. Hoepelman Netherlands 24 219 0.5× 698 1.5× 166 0.4× 307 1.1× 54 0.3× 66 1.4k
A. M. Geddes United Kingdom 22 383 0.8× 429 0.9× 268 0.7× 339 1.2× 53 0.3× 99 1.5k
B. Byl Belgium 24 169 0.4× 771 1.6× 302 0.8× 573 2.0× 125 0.7× 50 1.9k
Rose Jung United States 18 219 0.5× 310 0.7× 424 1.1× 89 0.3× 64 0.4× 38 1.2k
Isabel Machuca Spain 17 342 0.7× 320 0.7× 750 2.0× 255 0.9× 139 0.8× 43 1.2k
Farzin Khorvash Iran 18 99 0.2× 266 0.6× 210 0.6× 340 1.2× 41 0.2× 109 1.1k
Thomas R. Beam United States 17 247 0.5× 401 0.8× 166 0.4× 167 0.6× 43 0.3× 45 869

Countries citing papers authored by Jan G. den Hollander

Since Specialization
Citations

This map shows the geographic impact of Jan G. den Hollander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan G. den Hollander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan G. den Hollander more than expected).

Fields of papers citing papers by Jan G. den Hollander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan G. den Hollander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan G. den Hollander. The network helps show where Jan G. den Hollander may publish in the future.

Co-authorship network of co-authors of Jan G. den Hollander

This figure shows the co-authorship network connecting the top 25 collaborators of Jan G. den Hollander. A scholar is included among the top collaborators of Jan G. den Hollander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan G. den Hollander. Jan G. den Hollander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Brakenhoff, Sylvia M., Pieter Honkoop, Jan G. den Hollander, et al.. (2022). Patients treated with rituximab are poorly screened for hepatitis B infection: Data from a low-incidence country. European Journal of Internal Medicine. 108. 68–73. 1 indexed citations
3.
Bout, Christiaan J. van den, Rikje Ruiter, Jan G. den Hollander, et al.. (2021). High-flow Nasal Cannula therapy: A feasible treatment for vulnerable elderly COVID-19 patients in the wards. Heart & Lung. 50(5). 654–659. 11 indexed citations
4.
Boer, Dirk P., et al.. (2020). Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin. SHILAP Revista de lepidopterología. 1. 100006–100006. 1 indexed citations
5.
Kuijper, T. Martijn, Jan G. den Hollander, Radjesh J. Bisoendial, et al.. (2020). Predicting Severe COVID-19 at Presentation, Introducing the COVID Severity Score. SSRN Electronic Journal. 4 indexed citations
6.
Haverkate, Manon, Mirjam J. D. Dautzenberg, Anneke van der Zee, et al.. (2015). Within-Host and Population Transmission of blaOXA-48 in K. pneumoniae and E. coli. PLoS ONE. 10(10). e0140960–e0140960. 20 indexed citations
7.
Hoorn, Ewout J., Jan van Laar, Jan G. den Hollander, Johan M. Kros, & Esther Brusse. (2010). Three diagnoses become one: a woman with ground-glass attenuation develops fever. Thorax. 65(3). 214–214.
8.
Hollander, Jan G. den, Bronno van der Holt, Bart Rijnders, et al.. (2007). Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms. Journal of Antimicrobial Chemotherapy. 60(5). 1104–1107. 67 indexed citations
9.
Hollander, Jan G. den. (2006). Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections. Journal of Antimicrobial Chemotherapy. 57(6). 1248–1250. 50 indexed citations
10.
Götz, Hannelore M, Gerard van Doornum, Hubert G.M. Niesters, et al.. (2005). A cluster of acute hepatitis C virus infection among men who have sex with men – results from contact tracing and public health implications. AIDS. 19(9). 969–974. 187 indexed citations
11.
Hollander, Jan G. den, et al.. (2005). Correlation between severity of thyroid dysfunction and renal function. Clinical Endocrinology. 62(4). 423–427. 199 indexed citations
12.
Hollander, Jan G. den, et al.. (2004). [Sexual transmission of hepatitis C in homosexual men].. PubMed. 148(47). 2309–12. 8 indexed citations
13.
Vinks, Alexander A., Jan G. den Hollander, Shelley E. Overbeek, Roger W. Jelliffe, & Johan W. Mouton. (2003). Population Pharmacokinetic Analysis of Nonlinear Behavior of Piperacillin during Intermittent or Continuous Infusion in Patients with Cystic Fibrosis. Antimicrobial Agents and Chemotherapy. 47(2). 541–547. 45 indexed citations
14.
Schiffelers, Raymond M., Gert Storm, Marian T. ten Kate, et al.. (2002). LIPOSOME-ENABLED SYNERGISTIC INTERACTION OF ANTIMICROBIAL AGENTS. Journal of Liposome Research. 12(1-2). 121–127. 5 indexed citations
15.
Hollander, Jan G. den, Johan W. Mouton, & Henri A. Verbrugh. (1998). Use of Pharmacodynamic Parameters To Predict Efficacy of Combination Therapy by Using Fractional Inhibitory Concentration Kinetics. Antimicrobial Agents and Chemotherapy. 42(4). 744–748. 72 indexed citations
16.
Hollander, Jan G. den, Jenny Dahl Knudsen, Johan W. Mouton, et al.. (1998). Comparison of Pharmacodynamics of Azithromycin and Erythromycin In Vitro and In Vivo. Antimicrobial Agents and Chemotherapy. 42(2). 377–382. 37 indexed citations
17.
Mouton, Johan W., Hubert P. Endtz, Jan G. den Hollander, Nicole van den Braak, & H.A. Verbrugh. (1997). In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis. Journal of Antimicrobial Chemotherapy. 39(suppl 1). 75–80. 23 indexed citations
18.
Hollander, Jan G. den, et al.. (1996). Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model. Antimicrobial Agents and Chemotherapy. 40(3). 784–786. 14 indexed citations
19.
Hollander, Jan G. den, et al.. (1996). Enzymatic method for inactivation of aminoglycosides during measurement of postantibiotic effect. Antimicrobial Agents and Chemotherapy. 40(2). 488–490. 11 indexed citations
20.
Mouton, Johan W., et al.. (1993). Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Journal of Antimicrobial Chemotherapy. 31(6). 919–926. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra L. Preston Breakdown of academic impact, for papers by Laurel C. Preheim Breakdown of academic impact, for papers by Katie E. Barber Breakdown of academic impact, for papers by I. M. Hoepelman Breakdown of academic impact, for papers by A. M. Geddes Breakdown of academic impact, for papers by B. Byl Breakdown of academic impact, for papers by Rose Jung Breakdown of academic impact, for papers by Isabel Machuca Breakdown of academic impact, for papers by Farzin Khorvash Breakdown of academic impact, for papers by Thomas R. Beam
Rankless by CCL
2026